Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe

被引:20
|
作者
Makamure, Beauty [1 ]
Mhaka, Jesca [1 ]
Makumbirofa, Salome [1 ]
Mutetwa, Reggie [1 ]
Mupfumi, Lucy [1 ]
Mason, Peter [1 ,2 ]
Metcalfe, John Z. [3 ]
机构
[1] Biomed Res & Training Inst, Harare, Zimbabwe
[2] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe
[3] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Int TB Ctr, San Francisco, CA 94143 USA
来源
PLOS ONE | 2013年 / 8卷 / 02期
基金
美国国家卫生研究院;
关键词
MULTIDRUG-RESISTANT; PREVALENCE; CULTURE; AFRICA; TRIAL;
D O I
10.1371/journal.pone.0055872
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. Methods: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referred for culture and drug-susceptibility testing between April 1, 2011 and March 1, 2012. The diagnostic accuracy of MODS was estimated against a reference standard including Lowenstein-Jensen (LJ) media and manual liquid (BACTEC MGIT) culture. The accuracy of MODS drug-susceptibility testing (DST) was assessed against a reference standard absolute concentration method. Results: One hundred thirty-eight sputum samples were collected from 99 drug-resistant TB suspects; in addition, six previously cultured MDR isolates were included for assessment of DST accuracy. Among persons with known HIV infection status, 39/59 (66%) were HIV-infected. Eighty-six percent of patients had a history of prior TB treatment, and 80% of individuals were on antituberculous treatment at the time of sample collection. M. tuberculosis was identified by reference standard culture among 34/98 (35%) MDR-TB suspects. Overall MODS sensitivity for M. tuberculosis detection was 85% (95% CI, 69-95%) and specificity was 93% (95% CI, 84-98%); diagnostic accuracy did not significantly differ by HIV infection status. Median time to positivity was significantly shorter for MODS (7 days; IQR 7-15 days) than MGIT (12 days; IQR 6-16 days) or LJ (28 days; IQR 21-35 days; p < 0.001). Of 33 specimens with concurrent DST results, sensitivity of the MODS assay for detection of resistance to isoniazid, rifampin, and MDR-TB was 88% (95% CI, 68-97%), 96% (95% CI, 79-100%), and 91% (95% CI, 72-99%), respectively; specificity was 89% (95% CI, 52-100%), 89% (95% CI, 52-100%), and 90% (95% CI, 56-100%), respectively. Conclusion: In a high HIV-prevalence setting, MODS diagnosed TB and drug-resistant TB with high sensitivity and shorter turnaround time compared with standard culture and DST methods.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide
    Ghiraldi, L. D.
    Campanerut, P. A. Z.
    Spositto, F. L. E.
    Sato, D. N.
    Leite, C. Q. F.
    Hirata, M.
    Hirata, R. D. C.
    Cardoso, R. F.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (12) : 1792 - 1797
  • [42] Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali
    Sanogo, M.
    Kone, B.
    Diarra, B.
    Maiga, M.
    Baya, B.
    Somboro, A. M.
    Sarro, Y. S.
    Togo, A. C. G.
    Dembele, B. P. P.
    Goita, D.
    Kone, A.
    M'Baye, O.
    Coulibaly, N.
    Diabate, S.
    Traore, B.
    Diallo, M. H.
    Coulibaly, Y. I.
    Saleeb, P.
    Belson, M.
    Orsega, S.
    Siddiqui, S.
    Polis, M. A.
    Dao, S.
    Murphy, R. L.
    Diallo, S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (06) : 408.e1 - 408.e6
  • [43] Performance of GenoType® MTBDRplus assay in the diagnosis of drug-resistant tuberculosis in Tangier, Morocco
    Karimi, Hind
    En-Nanai, Latifa
    Oudghiri, Amal
    Chaoui, Imane
    Laglaoui, Amin
    Eddine Bourkadi, Jamal
    El Mzibri, Mohammed
    Abid, Mohammed
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 12 : 63 - 67
  • [44] Drug-resistant tuberculosis
    Nations, Joel Anthony
    Lazarus, Angeline A.
    Walsh, Thomas E.
    DM DISEASE-A-MONTH, 2006, 52 (11-12): : 435 - 440
  • [45] DRUG-RESISTANT TUBERCULOSIS
    不详
    BRITISH MEDICAL JOURNAL, 1981, 283 (6287): : 336 - 337
  • [46] DRUG-RESISTANT TUBERCULOSIS
    HANNA, BA
    BONK, S
    TICK, LK
    LANCET, 1993, 342 (8885): : 1496 - 1496
  • [47] DRUG-RESISTANT TUBERCULOSIS
    DUERDEN, BI
    BRITISH MEDICAL JOURNAL, 1995, 310 (6984): : 940 - 940
  • [48] DRUG-RESISTANT TUBERCULOSIS
    SNIDER, DE
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (03): : 732 - 732
  • [49] DRUG-RESISTANT TUBERCULOSIS
    BASS, JB
    KIRKPATRICK, MB
    SEMINARS IN RESPIRATORY MEDICINE, 1988, 9 (05): : 470 - 473
  • [50] The Coming of Age of Drug-Susceptibility Testing for Tuberculosis
    Cox, Helen
    Mizrahi, Valerie
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1474 - 1475